1. 7-ketocholesterol and 27-hydroxycholesterol decreased doxorubicin sensitivity in breast cancer cells: estrogenic activity and mTOR pathway
    Chun-Wei Wang et al, 2017, Oncotarget CrossRef
  2. Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma
    Andrea Magali González-Mora et al, 2021, International Journal of Molecular Sciences CrossRef
  3. Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
    Katharine Yu et al, 2023, Frontiers in Oncology CrossRef
  4. Deep graph embedding for prioritizing synergistic anticancer drug combinations
    Peiran Jiang et al, 2020, Computational and Structural Biotechnology Journal CrossRef

  5. Resistance and Overcoming Resistance in Breast Cancer


    Andrea Luque-Bolivar et al, 2020, Breast Cancer: Targets and Therapy CrossRef
  6. SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction
    Tian-Hao Li et al, 2023, Briefings in Bioinformatics CrossRef
  7. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro
    Beynon Abrahams et al, 2024, International Journal of Molecular Sciences CrossRef
  8. Using response surface models to analyze drug combinations
    Nathaniel R. Twarog et al, 2021, Drug Discovery Today CrossRef
  9. A Comprehensive Review on Deep Synergistic Drug Prediction Techniques for Cancer
    Vijay Kumar et al, 2022, Archives of Computational Methods in Engineering CrossRef
  10. MMSyn: A New Multimodal Deep Learning Framework for Enhanced Prediction of Synergistic Drug Combinations
    Yu Pang et al, 2024, Journal of Chemical Information and Modeling CrossRef
  11. A Factorization Machine Based Deep Neural Network for Synergism of Cancer Drug Combinations Prediction
    Xin Ma et al, 2021, 2021 4th International Conference on Pattern Recognition and Artificial Intelligence (PRAI) CrossRef
  12. A review of machine learning approaches for drug synergy prediction in cancer
    Anna Torkamannia et al, 2022, Briefings in Bioinformatics CrossRef
  13. Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance
    Sruthi Sritharan et al, 2022, Apoptosis CrossRef
  14. GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells
    Marthe-Susanna Wegner et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
  15. DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks
    Mengdie Xu et al, 2023, Journal of Cheminformatics CrossRef
  16. Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five
    Caroline Manto Chagas et al, 2018, International Journal of Pharmaceutics CrossRef
  17. Artificial intelligence techniques for prediction of drug synergy in malignant diseases: Past, present, and future
    Pooja Rani et al, 2022, Computers in Biology and Medicine CrossRef